Fatty acids, lipid metabolism and Alzheimer pathology

Eur J Pharmacol. 2008 May 6;585(1):176-96. doi: 10.1016/j.ejphar.2007.11.081. Epub 2008 Feb 29.

Abstract

Alzheimer's disease is the most common form of dementia in the elderly. The cause of Alzheimer's disease is still unknown and there is no cure for the disease yet despite 100 years of extensive research. Cardiovascular risk factors such as high serum cholesterol, presence of the Apolipoprotein epsilon4 (APOE epsilon4) allele and hypertension, play important roles in the development of Alzheimer's disease. We postulate that a combination of diet, lifestyle, vascular, genetic, and amyloid related factors, which enhance each other's contribution in the onset and course of Alzheimer's disease, will be more likely the cause of the disease instead of one sole mechanism. The possibility that the risk for Alzheimer's disease can be reduced by diet or lifestyle is of great importance and suggests a preventative treatment in Alzheimer's disease. Because of the great importance of lipid diets and metabolism in preventative treatment against both Alzheimer's disease and cardiovascular disease, long-chain polyunsaturated fatty acids from fish oil, ApoE genotype and cholesterol metabolism in correlation with Alzheimer's disease will be reviewed.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / epidemiology*
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Alzheimer Disease / prevention & control
  • Animals
  • Apolipoprotein E4 / genetics
  • Apolipoprotein E4 / metabolism
  • Brain / blood supply
  • Brain / metabolism
  • Brain / pathology
  • Cholesterol / metabolism
  • Energy Intake
  • Fatty Acids, Omega-3 / metabolism*
  • Humans
  • Life Style
  • Lipid Metabolism*
  • Risk Factors

Substances

  • Apolipoprotein E4
  • Fatty Acids, Omega-3
  • Cholesterol